Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study
Lisa Noguchi(Johns Hopkins University), Jeanne Marrazzo(St. Vincent's Birmingham), Sharon L. Hillier(Magee-Womens Research Institute), Gonasagrie Nair, Jeanna Piper(National Institute of Allergy and Infectious Diseases), Jennifer E. Balkus(Infectious Disease Research Institute), Zvavahera M. Chirenje(Global Brain Health Institute), D. Heather Watts(National Institutes of Health), Jared M. Baeten(University of Washington), Thesla Palanee‐Phillips(University of the Witwatersrand), Ariane van der Straten(University of California, San Francisco), Barbra A. Richardson(University of Washington), Urvi M. Parikh(University of Pittsburgh), Gita Ramjee(Aurum Institute), Katherine Bunge(Fred Hutch Cancer Center), Kailazarid Gomez(Family Health International 360), Pearl Selepe(Aurum Institute)
Cited by 52
Related Papers
Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women
|New England Journal of Medicine|2012|3.3k
Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women
|New England Journal of Medicine|2015|1.3k
Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
|The Lancet|2010|958
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women
|New England Journal of Medicine|2021|891
Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women
|New England Journal of Medicine|2016|768